AVANIR Pharmaceuticals, Inc. focuses on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States and Canada. Its lead product candidate includes Nuedexta, which has completed three Phase III clinical trials for the treatment of pseudobulbar affect
BTW, hope your shoulder has healed.
bonncaruso 3 weeks ago
AVANIR Pharmaceuticals, Inc. focuses on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States and Canada. Its lead product candidate includes Nuedexta, which has completed three Phase III clinical trials for the treatment of pseudobulbar affect
ososilver 10 months ago
Simply awesome
andrewsorrells77 1 year ago